EastPharma Ltd. reported audited consolidated earnings results for the full year ended December 31, 2011. For the quarter, revenue was $242,263,513 against $253,815,680 a year ago. Loss before tax was $16,531,771 against $2,873,867 a year ago. Net loss for the year attributable to equity holders of the parent was $18,059,267 or $0.28 per basic and diluted share against $2,446,028 or $0.02 per basic and diluted share a year ago. Net cash provided by operating activities was $9,574,149 against $5,859,301 a year ago. Purchases of property, plant and equipment was $23,122,201 against $17,615,378 a year ago.